Obesity is a major complex health concern with an increasing prevalence. Approximately 1.9 billion adults are overweight, and 610 million adults are obese (
1,
2). Furthermore, obesity is associated with other health concerns such as diabetes, cardiovascular disease, and hypertension, all of which result in decreased life expectancy and quality of life (
3). Metabolic and bariatric surgery is considered one of the safest and best choices for severe obesity, resulting in long-term weight loss (
4,
5), improvement of obesity-related morbidity (
6-
9), and decreased mortality (
10,
11) compared with nonsurgical options. The most common metabolic and bariatric surgeries are Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG) (
12). Due to its higher effectiveness and fewer postoperative complications, LSG is considered the preferred procedure for bariatric surgery (
13,
14). Bariatric procedures are associated with various micronutrient and vitamin deficiencies, such as deficiencies in zinc, vitamin B12, and vitamin D (
15,
16).
Vitamin D is a steroid hormone pivotal for calcium homeostasis and bone mineralization. Furthermore, vitamin D is involved in many nonclassical actions, and vitamin D deficiency is related to cancer, diabetes, cardiovascular, and autoimmune diseases (
17). There are concerns that serum vitamin D levels may be adversely affected by bariatric surgery (
18). Studies have demonstrated that following bariatric surgery, mean vitamin D levels remained ≤ 30 ng/mL (75 nmol/L) despite various vitamin D replacement therapies (
19). However, other studies have shown no significant difference in vitamin D levels after surgery (
20).